Nurix Therapeutics Inc (NRIX) Ownership

14.31 ↓0.14 (-0.93%)
As of April 19, 2024, 10:42am EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Nurix Therapeutics Inc (NRIX), owning a total of 4.6 million shares. Combined, the top 30 institutional holders of NRIX own 95.03% of the company with a total of 46.3 million shares.

In the latest ownership report on December 31st 2023, the top 30 institutional holders increased their combined ownership of NRIX by 3 million shares. 10 institutions bought 5,109,746 total additional shares and increased their ownership by an average of 141.20%. However 6 institutions sold 2,087,981 total shares and decreased their ownership by an average of 18.96%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Nurix Therapeutics Inc increased by a net total of 3,021,765 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc9.498%2.770%4,643,736125,1822023-12-31
Baker Bros Advisors LP7.940%0.000%3,882,12502023-12-31
ARK Investment Management LLC6.535%23.214%3,194,999601,9522023-12-31
Morgan Stanley - Brokerage Accounts6.412%1,137.130%3,135,0372,881,6242023-12-31
Deep Track Capital, LP6.131%0.000%2,997,83002023-12-31
Wasatch Advisors Inc.5.624%-22.860%2,749,745-814,8712023-12-31
Vanguard Group Inc5.314%-4.300%2,598,097-116,7482023-12-31
T. Rowe Price Associates, Inc.4.888%0.504%2,389,96611,9882023-12-31
Bain Capital Life Sciences Investors, LLC3.728%0.000%1,822,88302023-12-31
Geode Capital Management, LLC2.210%3.371%1,080,52335,2382023-12-31
Dimensional Fund Advisors, Inc.2.045%4.384%1,000,04442,0012023-12-31
State Street Corporation1.884%-48.067%921,322-852,7462023-12-31
Candriam Luxembourg S.C.A.1.878%-5.165%918,110-50,0002023-12-31
Pictet Asset Manangement SA1.582%-13.836%773,588-124,2212023-12-31
TCG Crossover Management, LLC1.468%0.000%717,654717,6542023-12-31
Affinity Asset Advisors, LLC1.411%176.045%690,112440,1122023-12-31
Charles Schwab Investment Management Inc1.273%9.448%622,29753,7212023-12-31
Goldman Sachs Group Inc1.153%55.092%563,800200,2742023-12-31
Nuveen Asset Management, LLC1.092%-19.509%533,865-129,3952023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc9.498%2.770%4,643,736125,1822023-12-31
Baker Bros Advisors LP7.940%0.000%3,882,12502023-12-31
ARK Investment Management LLC6.535%23.214%3,194,999601,9522023-12-31
Morgan Stanley - Brokerage Accounts6.412%1,137.130%3,135,0372,881,6242023-12-31
Deep Track Capital, LP6.131%0.000%2,997,83002023-12-31
Redmile Group, LLC5.827%-0.297%2,848,827-8,4822023-09-30
Wasatch Advisors Inc.5.624%-22.860%2,749,745-814,8712023-12-31
Vanguard Group Inc5.314%-4.300%2,598,097-116,7482023-12-31
T. Rowe Price Associates, Inc.4.888%0.504%2,389,96611,9882023-12-31
TRV GP III, LLC4.078%0.000%1,922,54902022-06-30
Bain Capital Life Sciences Investors, LLC3.728%0.000%1,822,88302023-12-31
Boxer Capital LLC2.505%0.000%1,224,89202023-09-30
Geode Capital Management, LLC2.210%3.371%1,080,52335,2382023-12-31
Dimensional Fund Advisors, Inc.2.045%4.384%1,000,04442,0012023-12-31
T. Rowe Price Investment Management,Inc.2.099%0.000%992,428992,4282022-09-30
State Street Corporation1.884%-48.067%921,322-852,7462023-12-31
Candriam Luxembourg S.C.A.1.878%-5.165%918,110-50,0002023-12-31
Soleus Capital Management, L.P.1.678%0.000%814,000814,0002023-09-30
Pictet Asset Manangement SA1.582%-13.836%773,588-124,2212023-12-31
TCG Crossover Management, LLC1.468%0.000%717,654717,6542023-12-31
Affinity Asset Advisors, LLC1.411%176.045%690,112440,1122023-12-31
Foresite Capital Management IV, LLC1.436%-34.309%677,143-353,6552022-06-30
Millennium Management LLC1.329%39.606%644,411182,8192023-06-30
Charles Schwab Investment Management Inc1.273%9.448%622,29753,7212023-12-31
Goldman Sachs Group Inc1.153%55.092%563,800200,2742023-12-31
Dafna Capital Management LLC1.139%0.000%556,69502023-09-30
Bank of America Corp1.118%-7.070%546,450-41,5752023-09-30
Nuveen Asset Management, LLC1.092%-19.509%533,865-129,3952023-12-31
Northern Trust Corp0.902%2.849%440,85212,2102023-09-30
FMR Inc0.859%-53.735%416,613-483,8752023-06-30

Mutual Fund Ownership

ARK Genomic Revolution is the biggest individual fund holder of Nurix Therapeutics Inc (NRIX), owning a total of 3.2 million shares. Combined, the top 28 mutual fund holders of NRIX own 51.26% of the company with a total of 25 million shares.

In the latest ownership report on February 29th 2024, the top 28 fund holders increased their combined ownership of NRIX by 13 thousand shares. 1 funds bought 13,998 total additional shares and increased their ownership by an average of 0.51%. However 2 funds sold 976 total shares and decreased their ownership by an average of 0.07%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Nurix Therapeutics Inc increased by a net total of 13,022 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF5.663%0.508%2,768,69413,9982024-02-29
Vanguard Total Stock Mkt Idx Inv2.923%0.000%1,429,34902024-02-29
iShares Russell 2000 ETF2.387%-0.016%1,166,946-1912024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.384%-0.116%676,886-7852024-02-29
Belfius Equities Cure C Cap1.152%0.000%563,09602024-02-29
Candriam Eqs L Biotech C USD Cap0.726%0.000%354,99202024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution6.474%23.148%3,165,329594,9762023-12-31
ARK Genomic Revolution ETF5.663%0.508%2,768,69413,9982024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr3.240%29.436%1,571,546357,4002023-03-31
Vanguard Total Stock Mkt Idx Inv2.923%0.000%1,429,34902024-02-29
T. Rowe Price New Horizons2.705%-0.319%1,322,383-4,2272023-12-31
US Small-Cap Growth II Equity Comp2.705%-0.319%1,322,383-4,2272023-12-31
iShares Russell 2000 ETF2.387%-0.016%1,166,946-1912024-02-29
Eventide Healthcare & Life Sciences I2.448%-38.289%1,154,000-716,0002022-06-30
Wasatch Ultra Growth1.975%11.335%965,61098,3072023-12-31
Wasatch Small Cap Growth Investor1.852%-2.514%898,101-23,1602023-09-30
SPDR® S&P Biotech ETF1.814%-0.489%879,614-4,3202023-11-30
Wasatch Small Cap Value1.438%29.273%702,910159,1682023-12-31
Vanguard Institutional Extnd Mkt Idx Tr1.384%-0.116%676,886-7852024-02-29
Vanguard Extended Market Index Investor1.278%-0.029%616,077-1812023-08-31
UBS: US Equity Small Cap Growth1.205%0.000%589,17602023-09-30
Candriam Global Equities Oncology1.152%-8.155%563,096-50,0002023-12-31
Belfius Equities Cure C Cap1.152%0.000%563,09602024-02-29
TIAA-CREF Quant Small-Cap Equity Instl1.026%20.000%501,61083,6002024-01-31
Xtrackers S&P Global Infra Swap ETF 1C0.989%0.000%483,68802023-12-31
Fidelity Small Cap Index0.970%1.193%474,2185,5912023-12-31
Fidelity® Small Cap Index0.940%1.146%456,1115,1682023-10-31
iShares Russell 2000 Value ETF0.924%0.127%451,7075722024-02-01
Pictet-Biotech P USD0.846%-17.666%413,378-88,6952023-12-31
T. Rowe Price Small-Cap Value0.828%-30.260%390,408-169,4002022-09-30
Fidelity® Select Biotechnology0.756%0.000%366,64602023-08-31
Pictet-Global Megatrend Sel I USD0.745%5.347%364,18518,4832023-12-31
Candriam Eqs L Biotech C USD Cap0.726%0.000%354,99202024-02-29
Wasatch Micro Cap0.721%27.338%352,48275,6732023-12-31

Discussions

Please log in or register to share your thoughts.

gangganggang11/28/22 12:32am

$NRIX the future is so bright .. I gotta wear shades..

0 Like Report